2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide,
C59 compound,
Wnt-C59,
Wnt-C59,
1243243-89-1,
2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide,
Wnt-C59 (C59),
CHEMBL2139947,
4-(2-Methyl-4-pyridinyl)-N-[4-(3-pyridinyl)phenyl]benzeneacetamide,
C25H21N3O,
C59,
2-[4-(2-methylpyridin-4-yl)phenyl]-n-[4-(pyridin-3-yl)phenyl]acetamide,
wnt-c59-c59,
WNTC59,
MLS006011203,
SCHEMBL1724609,
AOB3540,
DTXSID60727009,
EX-A289,
HMS3652D18,
BCP07008,
2142AH,
BDBM50133864,
MFCD22201167,
s7037,
ZINC68247444,
2-[4-(2-Methyl-pyridin-4-yl)-phenyl]-N-(4-pyridin-3-yl-phenyl)-acetamide,
AKOS024458516,
CS-1420,
QC-8389,
SB19435,
NCGC00263085-01,
AC-30233,
AK161197,
BC600407,
HY-15659,
OR302635,
SC-95553,
SMR004702972,
AB0097227,
AJ-117097,
AX8294157,
4CH-022746,
FT-0700434,
ST24039352,
SW220173-1,
W-5903,
J-690095,
2-[4-(2-methylpyridin-4-yl)phenyl]-N-(4-pyridin-3-ylphenyl)acetamide,
Benzeneacetamide, 4-(2-methyl-4-pyridinyl)-N-[4-(3-pyridinyl)phenyl]-,
Spautin-1,
KHZOJCQBHJUJFY-UHFFFAOYSA-N,
ACN-044767,
A8685,
A12951,
Wnt-C59, 98%, a potent PORCN enzymatic activity and Wnt inhibitor - 10MG 10mg,